| Combination chemotherapy in advanced adrenocortical carcinoma M Fassnacht, M Terzolo, B Allolio, E Baudin, H Haak, A Berruti, S Welin, ... New England Journal of Medicine 366 (23), 2189-2197, 2012 | 948 | 2012 |
| Efficacy of Selpercatinib in RET-Altered Thyroid Cancers LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, ... New England Journal of Medicine 383 (9), 825-835, 2020 | 731 | 2020 |
| Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification M Fassnacht, S Johanssen, M Quinkler, P Bucsky, HS Willenberg, ... Cancer 115 (2), 243-250, 2009 | 722 | 2009 |
| Integrated genomic characterization of adrenocortical carcinoma G Assié, E Letouzé, M Fassnacht, A Jouinot, W Luscap, O Barreau, ... Nature genetics 46 (6), 607-612, 2014 | 698 | 2014 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 687 | 2016 |
| Update in adrenocortical carcinoma M Fassnacht, M Kroiss, B Allolio The Journal of Clinical Endocrinology & Metabolism 98 (12), 4551-4564, 2013 | 496 | 2013 |
| Adrenocortical carcinoma: a clinician's update M Fassnacht, R Libé, M Kroiss, B Allolio Nature Reviews Endocrinology 7 (6), 323-335, 2011 | 492 | 2011 |
| Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ... The lancet oncology 16 (4), 426-435, 2015 | 371 | 2015 |
| Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection F Beuschlein, J Weigel, W Saeger, M Kroiss, V Wild, F Daffara, R Libé, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 841-849, 2015 | 363 | 2015 |
| Personalized management of pheochromocytoma and paraganglioma S Nölting, N Bechmann, D Taieb, F Beuschlein, M Fassnacht, M Kroiss, ... Endocrine reviews 43 (2), 199-239, 2022 | 312 | 2022 |
| A copeptin-based approach in the diagnosis of diabetes insipidus W Fenske, J Refardt, I Chifu, I Schnyder, B Winzeler, J Drummond, ... New England Journal of Medicine 379 (5), 428-439, 2018 | 273 | 2018 |
| Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study R Libe, I Borget, CL Ronchi, B Zaggia, M Kroiss, T Kerkhofs, J Bertherat, ... Annals of Oncology 26 (10), 2119-2125, 2015 | 260 | 2015 |
| Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells S Sbiera, E Leich, G Liebisch, I Sbiera, A Schirbel, L Wiemer, S Matysik, ... Endocrinology 156 (11), 3895-3908, 2015 | 225 | 2015 |
| Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ... Cancer discovery 11 (11), 2780-2795, 2021 | 204 | 2021 |
| Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial M Kroiss, M Quinkler, S Johanssen, NP van Erp, N Lankheet, A Pöllinger, ... The Journal of Clinical Endocrinology & Metabolism 97 (10), 3495-3503, 2012 | 199 | 2012 |
| Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study I Bancos, AE Taylor, V Chortis, AJ Sitch, C Jenkinson, CJ Davidge-Pitts, ... The lancet Diabetes & endocrinology 8 (9), 773-781, 2020 | 187 | 2020 |
| The role of surgery in the management of recurrent adrenocortical carcinoma I Erdogan, T Deutschbein, C Jurowich, M Kroiss, C Ronchi, M Quinkler, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), 181-191, 2013 | 183 | 2013 |
| Combination of lenvatinib and pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma C Dierks, J Seufert, K Aumann, J Ruf, C Klein, S Kiefer, M Rassner, ... Thyroid 31 (7), 1076-1085, 2021 | 179 | 2021 |
| Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer A Berruti, M Fassnacht, H Haak, T Else, E Baudin, P Sperone, M Kroiss, ... European urology 65 (4), 832-838, 2014 | 170 | 2014 |
| Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma S Wortmann, M Quinkler, C Ritter, M Kroiss, S Johanssen, S Hahner, ... European journal of endocrinology 162 (2), 349-356, 2010 | 168 | 2010 |